No trace of virus in imported goods, says Jubilant Life Sciences

- The firm’s Mysuru plant produces key ingredients for drugs used in treating respiratory tract infections
- The company is is also following all protocols for prevention of covid-19, in addition to taking welfare measures for employees and the community, while sharing information with authorities